Research Project
Grant-in-Aid for Challenging Exploratory Research
Raising HDL-cholesterol (C) has emerged as a potential strategy to tackle the residual risk that remains even after lowering LDL-C and triglyceride, in preventing cardiovascular disease. PEGylated and quaternized polyamine nanogel (Q-Nanogel) is a newly synthesized bile salt sequestering agent intended to treat dyslipidemia. We assessed the effects of Nanogel on dyslipidemia and atherosclerosis. Nanogel treatment resulted in a 35% reduction in plasma VLDL/LDL-C levels, a 58% increase in plasma HDL-C levels in C57BL/6J mice. In LDLR-/-mice, atherosclerotic lesion size with Nanogel was reduced by 45% compared to PBS. These data indicate that Nanogel not only decreased VLDL/LDL-C levels but also raised HDL-C levels. Nanogel could be a potential therapeutic candidate to raise HDL-C and the treatment of atherosclerosis.
All 2012 2011 Other
All Journal Article (13 results) (of which Peer Reviewed: 13 results) Presentation (10 results) Remarks (2 results) Patent(Industrial Property Rights) (1 results)
Am J Physiol Endocrinol Metab
Volume: 302(7) Pages: 896-902
Prog Lipid Res
Volume: (in press)
Volume: 302(7)
J Biol Chem
Volume: 286(32) Pages: 27902-14
Arterioscler Thromb Vasc Biol
Volume: 31(9) Pages: 1973-9
Volume: 286(47) Pages: 40835-46
Volume: 31(8) Pages: 1788-95
Arterioscle Thromb Vasc Biol
Lancet
Volume: 378(9786) Pages: 147-55
http://www.u-tsukuba-endocrinology.jp/